文献速递眼底病与葡萄膜炎

广域OCT血管成像与荧光素血管造影评估抗血管内皮生长因子治疗的糖尿病视网膜病变和水肿中的无灌注

Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.
PubMed 文献 · Ophthalmology · 2019-06-26

该观察性病例系列纳入9例患者10眼严重非增殖性或增殖性糖尿病视网膜病变伴糖尿病黄斑水肿,每月抗VEGF眼内注射3次。采用扫频源广域OCT血管成像与超广域荧光素血管造影评估无灌注,发现两种影像均未观察到无灌注区血管再灌注,且OCT血管成像对无灌注区的检出率更高。

要点

  • 抗VEGF治疗3次后,超广域荧光素血管造影和扫频源广域OCT血管成像均未见无灌注区血管或毛细血管网再灌注。
  • 扫频源广域OCT血管成像在基线检出无灌注区的比例高于超广域荧光素血管造影,额外检出无灌注区占29%(46/160)的方格。
  • 10眼中8眼糖尿病视网膜病变严重程度评分改善至少1期,微血管瘤和视网膜出血平均数量显著减少。

核心结论

  • 在糖尿病视网膜病变眼中,抗VEGF注射3次后,超广域荧光素血管造影和扫频源广域OCT血管成像均未检测到无灌注区血管或毛细血管网再灌注。
  • 扫频源广域OCT血管成像对无灌注区的检出率高于超广域荧光素血管造影。

研究设计与样本

  • 观察性病例系列,纳入9例患者10眼严重非增殖性糖尿病视网膜病变或增殖性糖尿病视网膜病变伴糖尿病黄斑水肿,启动每月抗VEGF眼内注射3次。
  • 所有眼在基线(M0)和第三次抗VEGF注射后1个月(M3)接受超广域彩色眼底照相、超广域荧光素血管造影和扫频源广域OCT血管成像。
  • 所有图像对齐并分为16个方格,由2名盲法视网膜专家分析无灌注区。

主要发现

  • 10眼中8眼糖尿病视网膜病变严重程度评分改善至少1期,超广域彩色眼底照相上微血管瘤和视网膜出血平均数量从M0的121±57显著减少至M3的40±28(P=0.0020),存在的眼底新生血管消退。
  • 荧光素血管造影检测到的所有无灌注区均可见于扫频源广域OCT血管成像,但扫频源广域OCT血管成像在M0额外检出无灌注区占29%(46/160)的方格。
  • M3时荧光素血管造影或扫频源广域OCT血管成像均未观察到小动脉或小静脉再灌注。
  • 视网膜毛细血管仅在OCT血管成像上可见,即使荧光素血管造影上暗区减少,无灌注区也未见再灌注。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess change in retinal nonperfusion (NP) after anti-vascular endothelial growth factor (VEGF) therapy for diabetic macular edema (DME) using 2 different imaging modalities: swept-source widefield (SS-WF) OCT angiography (OCTA) and ultra-widefield (UWF) fluorescein angiography (FA). DESIGN: Observational case series. PARTICIPANTS: Ten eyes of 9 patients with severe nonproliferative diabetic retinopathy (NPDR) or proliferative DR (PDR) initiating 3 monthly anti-VEGF intravitreal injections for DME. METHODS: All eyes were imaged with UWF color fundus photographs (CFPs), UWF FA, and SS-WF OCTA at baseline (M0) and 1 month after the third anti-VEGF injection (M3). All images were aligned and divided into 16 boxes for analysis of NP areas by 2 blinded retina specialists. MAIN OUTCOME MEASURES: The number of discrepancies between SS-WF OCTA and UWF FA regarding the detection of NP areas and small vessels passing through NP areas; assessment of DR severity on UWF CFP; and change in each NP area between M0 and M3: number of boxes/eye with presence of at least 1 NP area, number of arterioles or venules that disappeared or reappeared, and number of NP areas in which capillaries disappeared or reappeared. RESULTS: The diabetic retinopathy (DR) severity score improved by at least 1 stage in 8 of 10 eyes, with a significant decrease in the mean number of microaneurysms and retinal hemorrhages on UWF CFP at M3 versus M0 (n = 40±28 vs. 121±57; P = 0.0020) and regression of fundus neovascularization when present. All NP areas detected on FA were seen on SS-WF OCTA, but additional NP areas were detected on SS-WF OCTA at M0 in 29% (46/160) of boxes. No reperfusion of arterioles or venules was observed at M3 on FA or SS-WF OCTA. Retinal capillaries were only visible on OCTA, and no reperfusion in NP areas was observed even when a reduction in dark areas was visible on FA. CONCLUSIONS: No reperfusion of vessels or capillary network was detected in NP areas using 2 imaging techniques, UWF FA and SS-WF OCTA, in eyes with DR after 3 anti-VEGF injections. The detection rate of NP areas was higher with SS-WF OCTA than with UWF FA.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Couturier A, Rey PA, Erginay A, et al. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor. Ophthalmology. 2019. PMID: 31383483. doi:10.1016/j.ophtha.2019.06.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。